EIF2AK2 and cancer: We proceed to show that our methodology is effective in identifying novel mutational clusters that are missed by NMC in key cancer proteins such as KRAS and PIK3C α. Unlike NMC, iPAC is also able to identify the EGFR and EIF2AK2 proteins as containing mutational clustering as well.